Last updated on May 2019

ReNu Marrow Stimulation Augmentation

Brief description of study

To evaluate the use of ReNu allograft for the augmentation of marrow stimulation for osteochondral lesions

Detailed Study Description

This is a prospective, non-randomized, longitudinal study of up to 8 evaluable participants recruited from two separate practices. Male and non-pregnant female patients between the ages of 18 and 55 years of age will be screened for study recruitment. Female patients must be actively practicing a contraception method, abstinence, be surgically sterilized, or be postmenopausal. Participants will receive ReNu as an adjunct to their standard of care marrow stimulation for the treatment of osteochondral defects.

At each follow-up visit, concomitant medications and adverse events shall be collected from each subject, and each subject shall complete the following questionnaires:

IKDC Health Assessment (Includes Short Form-36) Tegner KOOS Knee Survey VAS Pain Scale SANE score

The subjects will be assessed at Baseline using these scales an again at all subsequent study follow-up visits.

Clinical Study Identifier: NCT03036878

Find a site near you

Start Over

Hospital for Special Surgery

New York, NY United States
  Connect »

Brigham and Women's Hospital

Chestnut Hill, MA United States
  Connect »


Indianapolis, IN United States
  Connect »